Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
David Jakeman | VP OF FINANCE AND ACCOUNTING | 2024-02-14 | 2,660 | $1.04 | $2.78kSell |
Michael T. Andriole | PRESIDENT AND CEO | 2024-02-14 | 1,744 | $1.04 | $1.81kSell |
Michelle Laspaluto | CHIEF FINANCIAL OFFICER | 2024-02-14 | 1,940 | $1.04 | $2.02kSell |
Fred A. Middleton | Director | 2023-11-17 | 17,295 | $0.96 | $16.52kBuy |
Fred A. Middleton | Director | 2023-11-10 | 2,705 | $0.92 | $2.49kBuy |
David Jakeman | VP of Finance and Accounting | 2023-09-28 | 3,610 | $0.99 | $3.58kSell |
Fred A. Middleton | Director | 2023-09-25 | 20,000 | $0.98 | $19.64kBuy |
Michael T. Andriole | President and CEO | 2023-08-01 | 25,000 | $1.19 | $29.75kBuy |
Michael T. Andriole | Chief Business Officer and CFO | 2023-05-18 | 51,700 | $1.14 | $59.14kBuy |
Michael A. Sherman | Chief Executive Officer | 2023-05-12 | 75,015 | $1.12 | $84.09kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ra Capital Management LP | 9.86% | 8,800,000 | $7.78M | Institution |
Monaco Asset Management Sam | 4.91% | 4,377,674 | $3.87M | Institution |
Vanguard Group Inc | 4.87% | 4,345,579 | $3.84M | Institution |
Sanderling Venture Partners V LP | 4.83% | 4,305,046 | $3.81M | Insider |
New Leaf Ventures Ii LP | 4.24% | 3,786,788 | $3.35M | Insider |
Cantex Pharmaceuticals Inc | 3.92% | 3,500,000 | $3.09M | Insider |
Timothy Wollaeger | 3.73% | 3,330,102 | $2.94M | Insider |
Armistice Capital LLC | 2.91% | 2,598,000 | $2.30M | Institution |
Canaan Vii LP | 2.90% | 2,584,990 | $2.29M | Insider |
Alta Biopharma Partners Iii LP | 2.42% | 2,161,829 | $1.91M | Insider |